Seeking Alpha

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

The real-world study will assess the clinical and operational impact of portable MRI across diverse patient types in ED settings. GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (HYPR), the ...
Hosted on MSN

Revelation Biosciences announces topline results from PRIME study

Revelation Biosciences (REVB) announced safety and activity data for its Phase 1b PRIME clinical study in stage 3 and 4 chronic kidney disease patients. The primary endpoint to evaluate the safety and ...
Seeking Alpha

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting

SALT LAKE CITY, Dec. 4, 2024 /PRNewswire/ -- Sera Prognostics, Inc. (SERA), The Pregnancy Company ® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy ...
USA Today

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

SAN DIEGO, CA / ACCESS Newswire / September 9, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on rebalancing ...
Nasdaq

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

Study represents a significant step forward in Company’s mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solutions MIAMI, Dec. 09, 2024 (GLOBE NEWSWIRE ...
Palm Beach Daily News

Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study

SAN DIEGO, CA / ACCESS Newswire / March 30, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on innovative solutions ...